Medicare Enrolled

Dr. Gregory Copeland, DO

Family Medicine · Clovis, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
255 W HERNDON AVE STE 103, Clovis, CA 93612
5595700070
In practice since 2007 (18 years)
NPI: 1154528123 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Copeland from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Copeland? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Copeland

Dr. Gregory Copeland is a family medicine specialist in Clovis, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Copeland performed 739 Medicare services across 547 unique beneficiaries.

Between the years covered by Open Payments, Dr. Copeland received a total of $10,767 from 63 pharmaceutical and/or device companies across 643 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Copeland is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 31% volume in CA $10,767 industry payments

Medicare Practice Summary

Medicare Utilization ↗
739
Medicare services
Top 31% in CA for family medicine
547
Unique beneficiaries
$86
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~41 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
423 $87 $309
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
78 $135 $326
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
52 $32 $114
Annual depression screening 50 $20 $50
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
48 $149 $309
Flu vaccine, quadrivalent
A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection.
46 $76 $179
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
42 $65 $213
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$10,767
Total received (2018-2024)
Avg $1,538/year across 7 years
Top 4% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
643
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,599 (98.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$168 (1.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,224
2023
$1,439
2022
$2,206
2021
$1,917
2020
$1,351
2019
$1,320
2018
$310

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$543
Novo Nordisk Inc
$278
Boehringer Ingelheim Pharmaceuticals, Inc.
$163
PFIZER INC.
$152
ABIOMED
$139
AstraZeneca Pharmaceuticals LP
$134
Amgen Inc.
$117
Exact Sciences Corporation
$108
ViiV Healthcare Company
$74
Lilly USA, LLC
$51
Otsuka Pharmaceutical Development & Commercialization, Inc.
$46
Otsuka America Pharmaceutical, Inc.
$44
Bayer Healthcare Pharmaceuticals Inc.
$37
SANOFI-AVENTIS U.S. LLC
$37
GlaxoSmithKline, LLC.
$32
AIMMUNE THERAPEUTICS, INC.
$32
Merck Sharp & Dohme LLC
$31
Daiichi Sankyo Inc.
$25
Xeris Pharmaceuticals, Inc.
$24
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$22
Inspire Medical Systems, Inc.
$20
E.R. Squibb & Sons, L.L.C.
$19
Abbott Laboratories
$18
Phathom Pharmaceuticals, Inc.
$17
Mylan Specialty L.P.
$16
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$16
Dexcom, Inc.
$16
Novartis Pharmaceuticals Corporation
$14
Top 3 companies account for 44.2% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$960
Amgen Inc.
$957
ABBVIE INC.
$856
AbbVie Inc.
$641
Novo Nordisk Inc
$614
AstraZeneca Pharmaceuticals LP
$577
Lilly USA, LLC
$543
PFIZER INC.
$491
GlaxoSmithKline, LLC.
$419
Novartis Pharmaceuticals Corporation
$406
Abbott Laboratories
$316
Janssen Pharmaceuticals, Inc
$315
Otsuka America Pharmaceutical, Inc.
$255
Daiichi Sankyo Inc.
$244
Astellas Pharma US Inc
$213
Takeda Pharmaceuticals U.S.A., Inc.
$199
Bayer Healthcare Pharmaceuticals Inc.
$189
Allergan, Inc.
$165
SK Life Science, Inc.
$158
Biohaven Pharmaceuticals, Inc.
$156
Bayer HealthCare Pharmaceuticals Inc.
$142
ABIOMED
$139
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$122
Biohaven Pharmaceutical Holding Company Ltd.
$115
Esperion Therapeutics, Inc.
$108
Exact Sciences Corporation
$108
Teva Pharmaceuticals USA, Inc.
$85
Kowa Pharmaceuticals America, Inc.
$75
ViiV Healthcare Company
$74
E.R. Squibb & Sons, L.L.C.
$73
AbbVie, Inc.
$72
Radius Health, Inc.
$67
Dynavax Technologies Corporation
$63
Amarin Pharma Inc.
$61
Merck Sharp & Dohme LLC
$55
Medtronic, Inc.
$53
Otsuka Pharmaceutical Development & Commercialization, Inc.
$46
Merck Sharp & Dohme Corporation
$43
BOSTON SCIENTIFIC CORPORATION
$41
Allergan Inc.
$39
Dexcom, Inc.
$38
SANOFI-AVENTIS U.S. LLC
$37
Arbor Pharmaceuticals, Inc.
$34
AIMMUNE THERAPEUTICS, INC.
$32
IDORSIA PHARMACEUTICALS US INC
$30
iRhythm Technologies, Inc.
$26
Almatica Pharma LLC
$25
Xeris Pharmaceuticals, Inc.
$24
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$22
Genentech USA, Inc.
$20
Advanced Respiratory, Inc
$20
Eisai Inc.
$20
Inspire Medical Systems, Inc.
$20
Lundbeck LLC
$18
Coloplast Corp
$18
Boston Scientific Corporation
$18
Phathom Pharmaceuticals, Inc.
$17
Mylan Specialty L.P.
$16
Nevro Corp.
$16
Hologic, LLC
$16
Horizon Therapeutics plc
$15
Seqirus USA Inc
$14
ARBOR PHARMACEUTICALS, INC.
$12
Top 3 companies account for 25.8% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · AJOVY · ANORO ELLIPTA · APRETUDE · Aimovig · AirDuo Digihaler · Altis · BELSOMRA · CAPLYTA · CHANTIX · COMIRNATY · COSENTYX · CREON · Cologuard Collection Kit · Corlanor · Creon · DOVATO · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Edarbi · FARXIGA · FASENRA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Fluad Quadrivalent · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GARDASIL · GARDASIL 9 · GRALISE · Heplisav-B · INJECTAFER · INSPIRE · INTELLIS · INTELLIS ADAPTIVESTIM · Impella · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · LEQVIO · LINZESS · LYRICA · Livalo · MAVYRET · MOUNJARO · MYRBETRIQ · NEXLETOL · NURTEC ODT · OFEV · Omnia · Otezla · Ozempic · PAXLOVID · PENNSAID · PNEUMOVAX 23 · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolia · QULIPTA · QUVIVIQ · RECORLEV · REXULTI · RYBELSUS · Repatha · Rybelsus · SEGLENTIS · SHINGRIX · SPECTRA WAVEWRITER · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · SYNCHROMED · SYNTHROID · Saxenda · Seglentis · Superion · THINPREP 2000 PROCESSOR · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TZIELD · The Vest System Model 105 Home Care · Trintellix · Tymlos · UBRELVY · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · Vyvanse · WaveWriter Alpha Prime 16 · Wegovy · XARELTO · XCOPRI · XIFAXAN · Xofluza · YUPELRI · ZENPEP · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for family medicine in CA.

Looking for a family medicine specialist in Clovis?
Compare family medicine physicians in the Clovis area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
354
Per 100K population
35.0
County median income
$71,434
Nearest hospital
CLOVIS COMMUNITY MEDICAL CENTER
1.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Copeland is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 4% of CA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Copeland experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Copeland performed 423 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Copeland receive payments from pharmaceutical companies?
Yes. Dr. Copeland received a total of $10,767 from 63 companies across 643 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Copeland's costs compare to other family medicine physicians in Clovis?
Dr. Copeland's average Medicare payment per service is $86. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Copeland) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →